C S Hesdorffer - JoVE Visualize

Showing results (11-20 of 27) with videos related to

Pageof 3

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999

Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cellsK P Papadopoulos, C S Hesdorffer, N Suciu-Foca, et al.

Clinical Nuclear Medicine|August 1, 1987

Radioisotopic flow scanning for portal blood flow and portal hypertensionC S Hesdorffer, W R Bezwoda, M D Danilewitz, et al.

Blood|January 7, 1998

Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blastsK P Papadopoulos, N Suciu-Foca, C S Hesdorffer, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999

Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxelR T Lee, M W Oster, C Balmaceda, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2005

Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic studyM D Stubblefield, L T Vahdat, C M Balmaceda, et al.

British Journal of Haematology|September 1, 2001

Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gammaF Moschella, A Maffei, R P Catanzaro, et al.

American Journal of Nephrology|October 31, 2001

Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literatureJ Lin, G S Markowitz, M Nicolaides, et al.

Clinical and Experimental Immunology|July 11, 2012

Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patientsH Lim, L Kane, J B Schwartz, et al.

Journal of Hematotherapy & Stem Cell Research|January 14, 2000

CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancerK P Papadopoulos, J Ayello, R F Reiss, et al.

Cancer Chemotherapy and Pharmacology|February 28, 2001

The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancerK P Papadopoulos, M J Egorin, M Huang, et al.

Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:

Pageof 3

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999

Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cellsK P Papadopoulos, C S Hesdorffer, N Suciu-Foca, et al.

Clinical Nuclear Medicine|August 1, 1987

Radioisotopic flow scanning for portal blood flow and portal hypertensionC S Hesdorffer, W R Bezwoda, M D Danilewitz, et al.

Blood|January 7, 1998

Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blastsK P Papadopoulos, N Suciu-Foca, C S Hesdorffer, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999

Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxelR T Lee, M W Oster, C Balmaceda, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2005

Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic studyM D Stubblefield, L T Vahdat, C M Balmaceda, et al.

British Journal of Haematology|September 1, 2001

Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gammaF Moschella, A Maffei, R P Catanzaro, et al.

American Journal of Nephrology|October 31, 2001

Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literatureJ Lin, G S Markowitz, M Nicolaides, et al.

Clinical and Experimental Immunology|July 11, 2012

Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patientsH Lim, L Kane, J B Schwartz, et al.

Journal of Hematotherapy & Stem Cell Research|January 14, 2000

CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancerK P Papadopoulos, J Ayello, R F Reiss, et al.

Cancer Chemotherapy and Pharmacology|February 28, 2001

The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancerK P Papadopoulos, M J Egorin, M Huang, et al.

Pageof 3